Q2 2026 13F · SEC CIK 1512020
Kepos Capital LP
Hedge fundFiled 2026-08-13 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $73.4M
- Reported positions
- 183
- Top holdings a year, 3 yrs
- +2.2%
- Assets under management
- $2.5B
Kepos Capital LP is a hedge fund that reported 183 positions worth $73.4M in its Q2 2026 13F, filed 2026-08-13. Its largest holdings were Cme Group Inc (CME, 9.0%), Cartesian Growth Corp IV (CGCFU, 3.1%), Forefront Tech Holdings Acquisition Corp (FTHA, 3.0%). A portfolio copying its top holdings returned 2.2% a year over the last 3 years, against 20.4% for the S&P 500.
Kepos Capital LP holdings largest 50 of 183 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Kepos Capital LP bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
No position grew by more than 5%.
Reduced
No position shrank by more than 5%.
Left the top 50
- DMIIU Drugs Made in Amer Acq II Cowas 3.4%
- CTAAU Clearthink 1 Acquisition Corwas 3.3%
- AACIU Armada Acquisition Corp IIIwas 2.4%
- MOZAYYX Acquisition Corp unitwas 2.3%
- GIXXU Gigcapital9 Corpwas 2.0%
- PAACU Proem Acquisition Corp Iwas 1.6%
- BHAVU Bhav Acquisition Corpwas 1.5%
- CAQUU Cambridge Acquisition Corpwas 1.4%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +5.3% /yr
- S&P 500 +20.1%
- 3 years
- +2.2% /yr
- S&P 500 +20.4%
- 5 years
- +1.4% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $73.4M | 183 |
| Q1 2026 | $61.3M | 147 |
| Q4 2025 | $17.6M | 36 |
| Q3 2025 | $18.8M | 40 |
| Q2 2025 | $74.6M | 46 |
| Q1 2025 | $120.7M | 52 |
| Q4 2024 | $115.7M | 56 |
| Q3 2024 | $228.2M | 224 |
| Q2 2024 | $257.5M | 225 |
| Q1 2024 | $387.9M | 254 |
| Q4 2023 | $308.5M | 221 |
| Q3 2023 | $565.3M | 283 |
Questions about Kepos Capital LP's portfolio
What stocks does Kepos Capital LP own?
Kepos Capital LP's latest 13F, for Q2 2026 and filed Aug 13, 2026, lists 183 positions worth $73.4M. The largest are Cme Group Inc (CME) at 9.0%, Cartesian Growth Corp IV (CGCFU) at 3.1%, Forefront Tech Holdings Acquisition Corp (FTHA) at 3.0%, Praetorian Acquisition Corp (PTOR) at 3.0% and Drugs Made in America Acquisition II Cor (DMII) at 2.9%.
What did Kepos Capital LP buy last quarter?
Kepos Capital LP opened no new positions and grew none by more than 5% among its largest holdings in Q2 2026.
What did Kepos Capital LP sell last quarter?
In Q2 2026, Kepos Capital LP cut from its top 50 Drugs Made in Amer Acq II Co (DMIIU), cut from its top 50 Clearthink 1 Acquisition Cor (CTAAU), cut from its top 50 Armada Acquisition Corp III (AACIU), cut from its top 50 MOZAYYX Acquisition Corp unit and cut from its top 50 Gigcapital9 Corp (GIXXU), compared with its Q1 2026 filing.
How has Kepos Capital LP's portfolio performed?
A portfolio copying Kepos Capital LP's 20 largest 13F holdings each quarter, from the day each filing was public, returned +2.2% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +5.3% against +20.1%. Over 5 years: +1.4% a year against +11.6%.
When is Kepos Capital LP's next 13F filing due?
13F filings are due 45 days after each quarter ends. Kepos Capital LP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Kepos Capital LP manage?
Kepos Capital LP reported $2.5B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $73.4M.